Australian Pharmaceutical Industries | API | Health care equipment & services
Performance | Valuation | Growth | Summary | Balance Sheet | Income Statement | Cash Flow
A$ in Million. Fiscal year ends in August. Figures are consolidated and restated.
2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | ||
Cash and cash equiva... | 43 | 6 | 29 | 35 | 20 | 23 | 24 | 28 | 25 | 40 | |
Short-term investment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 0 | 0 | |
Accounts receivables | 226 | 251 | 700 | 590 | 586 | 560 | 566 | 592 | 690 | 682 | |
Inventories | 269 | 290 | 322 | 320 | 314 | 336 | 342 | 364 | 414 | 399 | |
Deferred income taxes | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | |
Other current assets | 0 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Total current assets | 542 | 571 | 1,052 | 945 | 920 | 919 | 932 | 994 | 1,129 | 1,121 | |
Gross property plant... | 85 | 112 | 128 | 120 | 121 | 122 | 117 | 102 | 100 | 95 | |
Accumulated Depriciat... | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Net property, plant and Eq... | 85 | 112 | 128 | 120 | 121 | 122 | 117 | 102 | 100 | 95 | |
Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Miscellaneous Investment | 25 | 0 | 24 | 28 | 28 | 28 | 7 | 0 | 0 | 0 | |
Deferred income taxes | 9 | 14 | 10 | 34 | 37 | 40 | 34 | 23 | 20 | 20 | |
Intangible assets | 203 | 200 | 197 | 195 | 192 | 206 | 167 | 194 | 190 | 194 | |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Other long-term assets | 136 | 148 | 74 | 69 | 76 | 60 | 32 | 30 | 11 | 21 | |
Total non-current assets | 458 | 474 | 433 | 446 | 454 | 457 | 357 | 349 | 321 | 330 | |
Total assets | 999 | 1,045 | 1,485 | 1,391 | 1,373 | 1,376 | 1,289 | 1,343 | 1,450 | 1,451 | |
Short-term debt | 1 | 1 | 201 | 188 | 44 | 25 | 21 | 58 | 3 | 3 | |
Accounts Payable... | 549 | 578 | 673 | 569 | 563 | 607 | 615 | 666 | 799 | 804 | |
Provisions | 15 | 3 | 3 | 55 | 47 | 21 | 51 | 54 | 30 | 27 | |
Taxes Payable | 0 | 9 | 0 | 5 | 9 | 8 | 0.5 | 0 | 13 | 17 | |
Deferred Revenues | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Capital Leases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Total current liabilities | 565 | 591 | 876 | 817 | 663 | 661 | 687 | 778 | 846 | 851 | |
Long-term debt | 6 | 6 | 0.49 | 0.47 | 121 | 115 | 102 | 41 | 48 | 30 | |
Investments Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Deferred tax liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.53 | 0.36 | |
Provisions | 3 | 3 | 3 | 4 | 5 | 5 | 6 | 5 | 5 | 4 | |
Capital Leases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Other longterm liabilities | 7 | 13 | 14 | 15 | 17 | 11 | 14 | 14 | 14 | 12 | |
Total non-current liabilities | 15 | 21 | 17 | 20 | 142 | 131 | 122 | 59 | 67 | 46 | |
Total liabilities | 580 | 613 | 894 | 837 | 805 | 792 | 808 | 837 | 913 | 897 | |
Share Capital | 419 | 419 | 566 | 566 | 566 | 566 | 566 | 566 | 566 | 566 | |
Share premium | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Retained earnings | -0.54 | 13 | 25 | -6 | 15 | 31 | 19 | 44 | 75 | 92 | |
Accumulated other equity | 0 | 0 | 0 | -6 | -13 | -14 | -105 | -105 | -105 | -105 | |
Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Total Equity | 419 | 433 | 591 | 554 | 568 | 584 | 481 | 505 | 537 | 554 | |
Total Liabilities and Equity | 999 | 1,045 | 1,485 | 1,391 | 1,373 | 1,376 | 1,289 | 1,343 | 1,450 | 1,451 | |
Cash per Share | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | |
Cash, Current Inv Per share | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade | Upgrade |